This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In this issue of Neurology, two studies report changes in serotonergic function in the epileptic hippocampus of patients with temporal lobe epilepsy (TLE). In the first, Toczek et al.1 report decreased binding of the PET tracer [18F]FCWAY to the 5HT1A receptor in both medial and lateral temporal regions ipsilateral to the epileptic focus, as well as in the brain stem, of patients with TLE. In the second, Natsume et al.2 explored the role of serotonin synthesis in TLE with the PET tracer alpha[11C]methyl-L-tryptophan (AMT). They report increased AMT uptake in the hippocampus ipsilateral to the seizure focus of TLE patients with normal hippocampal volumes but not in patients with hippocampal atrophy. When examining the relationship between the results of AMT PET to glucose metabolism PET in the TLE group as a whole, Natsume et al.2 found decreased glucose metabolism in the lateral temporal and frontal lobes correlated with an increase in the regional uptake constant (K*) for AMT in the hippocampus. Conversely, they report higher ipsilateral lenticular nucleus and cingulate cortex glucose metabolism, which was correlated with increased hippocampal AMT K*. Both reports build upon previous basic studies exploring serotonergic mechanisms in …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Both of these studies report alterations of serotonergic function in brain regions outside the seizure focus.
- Does the increased hippocampal uptake of AMT represent altered metabolism of tryptophan by the serotonin or the kynurenine pathway in TLE?
- How do these studies increase our understanding of the pathophysiology in TLE?
- How do these studies affect clinical management of patients with TLE?
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Disclosures
